European Wellness Biomedical Group (EWBG) and Prestigious Ukrainian Institutions Sign Landmark MoU for Advancing Regenerative Medicine

On 2nd January 2024, the European Wellness Biomedical Group (EWBG) achieved a significant milestone by signing a groundbreaking Memorandum of Understanding (MoU) with four esteemed institutions in Ukraine: Bogomolets National Medical University (NMU), the Institute of Genetic and Regenerative Medicine, M.D. Strazhesko National Scientific Center of Cardiology, Clinical and Regenerative Medicine (INGEN), and the D.F. Chebotarev Institute of Gerontology under the National Academy of Medical Sciences of Ukraine (INGERONT).

The signing ceremony, conducted via a Zoom recording, was officiated in Kota Kinabalu, Malaysia. The MoU was signed by EWBG’s Founder and Chairman, Prof. Dato’ Sri Dr. Mike Chan, and witnessed by representatives, Prof. Dr. Olha Nishkumai, Prof. Dr. Yuriy Nalapko, Dr. Margaryta Iemelianova and Prof. Dr. Dmytro Klokol.

This strategic partnership aims to advance collaboration in integrative and biological wellness, regenerative medicine, and evidence-based healthcare solutions. By leveraging their collective resources, expertise, and knowledge, the signatories are dedicated to driving innovation in regenerative medicine and fostering academic excellence.

The collaboration highlights the shared vision of EWBG and its Ukrainian partners to improve global access to cutting-edge healthcare solutions. This partnership seeks to strengthen academic and research profiles while creating impactful and sustainable healthcare advancements to address pressing global challenges.

This MoU reflects the growing importance of international cooperation in pushing the boundaries of medical science and technology, particularly in genetic and regenerative medicine. It stands as a beacon for global partnerships committed to the pursuit of groundbreaking medical and scientific innovation.